Get the Stockscreener App
382.25
1.68%
-6.7995
Overview
News
Price History
Option Chain
Financials
Why HUM Down?
Discussions
Forecast
Dividend History
Humana Inc stock is traded at $382.25, with a volume of 355.46K.
It is down -1.68% in the last 24 hours and down -4.38% over the past month.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
See More
Previous Close:
$389.05
Open:
$386.52
24h Volume:
355.46K
Relative Volume:
0.25
Market Cap:
$45.87B
Revenue:
$137.20B
Net Income/Loss:
$1.15B
P/E Ratio:
40.91
EPS:
9.3439
Net Cash Flow:
$1.27B
1W Performance:
-0.83%
1M Performance:
-4.38%
6M Performance:
+106.77%
1Y Performance:
+33.56%
1-Day Range:
$380.06
$387.08
1-Week Range:
$370.38
$392.58
52-Week Range:
$163.11
$428.88
Humana Inc Stock (HUM) Company Profile
Name
Humana Inc
Sector
Industry
Phone
(502) 580-1000
Address
101 E. MAIN STREET, LOUISVILLE, KY
Compare HUM vs UNH, CVS, ELV, CI
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
381.99 | 46.72B | 137.20B | 1.15B | 1.27B | 9.3439 |
UNH
Unitedhealth Group Inc
|
394.46 | 360.59B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
93.95 | 124.26B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
388.91 | 86.82B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
275.33 | 74.66B | 278.13B | 6.74B | 7.66B | 23.60 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-12-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-02-26 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jan-07-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-05-25 | Upgrade | Jefferies | Hold → Buy |
| Oct-14-25 | Initiated | Goldman | Sell |
| Sep-22-25 | Initiated | Evercore ISI | In-line |
| May-01-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-06-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Oct-08-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-07-24 | Downgrade | Jefferies | Buy → Hold |
| Oct-07-24 | Downgrade | TD Cowen | Buy → Hold |
| Oct-03-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-02-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-02-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Oct-02-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| Jun-24-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-22-24 | Initiated | Raymond James | Mkt Perform |
| Mar-13-24 | Downgrade | Argus | Buy → Hold |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Jan-26-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jan-25-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-23 | Upgrade | Argus | Hold → Buy |
| Nov-08-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-07-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-23-23 | Downgrade | Argus | Buy → Hold |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Oct-26-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-20-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Initiated | Bernstein | Mkt Perform |
| Apr-13-22 | Upgrade | UBS | Neutral → Buy |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-04-21 | Reiterated | Barclays | Overweight |
| Nov-04-21 | Reiterated | Credit Suisse | Outperform |
| Nov-04-21 | Reiterated | Morgan Stanley | Overweight |
| Nov-04-21 | Reiterated | Oppenheimer | Outperform |
| Nov-04-21 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Sep-09-21 | Resumed | Barclays | Overweight |
| Jul-09-21 | Initiated | Seaport Global Securities | Neutral |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jan-04-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-02-20 | Initiated | Bernstein | Mkt Perform |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-16-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jun-05-20 | Initiated | Goldman | Buy |
| Jan-03-20 | Reiterated | JP Morgan | Overweight |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-12-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Apr-23-19 | Initiated | UBS | Neutral |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-20-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-08-18 | Reiterated | BofA/Merrill | Buy |
| Sep-13-18 | Initiated | Barclays | Overweight |
| Jul-12-18 | Resumed | Morgan Stanley | Overweight |
| Jul-06-18 | Reiterated | Piper Jaffray | Overweight |
| Jun-01-18 | Resumed | Citigroup | Buy |
| Feb-08-18 | Upgrade | Credit Suisse | Neutral → Outperform |
| Feb-08-18 | Reiterated | Leerink Partners | Outperform |
| Jan-12-18 | Upgrade | Jefferies | Hold → Buy |
View All
Humana Inc Stock (HUM) Latest News
Humana (NYSE:HUM) Home Care Push Puts Valuation In Focus - Kalkine Media
Humana Inc. (HUM) Stock Analysis: Exploring a 7% Potential Upside in the Healthcare Sector - directorstalkinterviews.com
Diamond Hill Capital Management LLC Investment Advisor Makes New Investment in Humana Inc. $HUM - MarketBeat
Law firm investigates Humana directors for poss... - Pluang
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire
7,351 Shares in Humana Inc. $HUM Purchased by S&CO Inc. - MarketBeat
Glenmark USA Agrees to USD 15.28 Mn Settlement With Humana Over Generic Drug Antitrust Claims - Medical Dialogues
Humana Stock Gains 1.1% as 600,000-Member Medicare Reset Tests Its 2028 Margin Plan - TechStock²
Oppenheimer Asset Management Inc. Makes New $9.05 Million Investment in Humana Inc. $HUM - MarketBeat
BlackRock Event Driven Equity Fund's Humana Inc(HUM) Holding History - GuruFocus
Humana Inc. stock outperforms competitors on strong trading day - MarketWatch
Brokers Set Expectations for Humana's Q3 Earnings (NYSE:HUM) - MarketBeat
Do Wall Street Analysts Like Humana Stock? - Barchart.com
Mirae Asset Global Investments Co. Ltd. Acquires 3,726 Shares of Humana Inc. $HUM - MarketBeat
3,146 Shares in Humana Inc. $HUM Purchased by Retireful LLC - MarketBeat
TriaGen Wealth Management LLC Purchases New Stake in Humana Inc. $HUM - MarketBeat
Humana Inc. $HUM Shares Sold by Cetera Investment Advisers - MarketBeat
Glenmark Will Pay $15.3M To End Humana's Price-Fixing Claims - Law360
CPI | Glenmark to Pay $15.3 Million to Settle Humana Antitrust Claims - PYMNTS.com
Can Humana Improve Caregiver Retention With HealthStream Deal? - The Globe and Mail
Equities Analysts Offer Predictions for Humana Q1 Earnings - MarketBeat
Humana (NYSE:HUM) Downgraded by Zacks Research to "Hold" - MarketBeat
Humana stock (HUM) climbs 3% as 2027 COLA calculations obscure rising medical-cost shortfall - TechStock²
Why Is Humana (NYSE:HUM) Betting Bigger on Medicaid and CenterWell? - Kalkine Media
Humana names new Medicaid president - The Business Journals
Medicare Will Spend More Than $13 Billion on the Medicare Advantage Quality Bonus Program in 2026 - KFF
Humana Inc. (HUM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Humana Inc (HUM) Stock Down 3.3% but Still Overvalued -- GF Scor - GuruFocus
Glenmark settles Humana antitrust lawsuit for $15.28 million - scanx.trade
Glenmark Pharma US arm agrees to $15.28 million settlement with Humana over antitrust lawsuits - CNBC TV18
Humana taps ex-Johns Hopkins exec as Medicaid leader - Healthcare Dive
Humana Healthy Horizons in Indiana Collaborates with HealthStream to Expand and Strengthen Home Care Workforce - Business Wire
James P. Holland to Join Humana as Medicaid President - Humana
Humana Names James P. Holland President of Medicaid - citybiz
Humana appoints James Holland to lead Medicaid business - Investing.com
Humana’s Incoming Medicaid President Will Lead Business in 11 States - Stock Titan
Humana Inc. (HUM) Stock Analysis: Evaluating Growth Potential With A 8.16% Upside - directorstalkinterviews.com
Bronstein, Gewirtz & Grossman, LLC Encourages Humana Inc. (HUM) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Humana Inc. $HUM Stock Position Decreased by Gradient Investments LLC - MarketBeat
Pacer Advisors Inc. Has $1.65 Million Stock Holdings in Humana Inc. $HUM - MarketBeat
180 Wealth Advisors LLC Cuts Stake in Humana Inc. $HUM - MarketBeat
Humana Inc. (HUM) Stock forecasts - Yahoo Finance Singapore
Humana Inc (HUM) Stock Up 4.8% but GF Value Says Overvalued -- G - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Is Investigating Humana Inc. (HUM) And Encourages Shareholders to Connect - ACCESS Newswire
Quantinno Capital Management LP Cuts Stock Position in Humana Inc. $HUM - MarketBeat
ANTITRUST—E.D. Pa.: Humana’s generic-drug price-fixing claims will proceed to bellwether trial - VitalLaw.com
Bank of America Corp DE Decreases Holdings in Humana Inc. $HUM - MarketBeat
Drug Cos. Can't Trim Humana's Price-Fix Claims In Bellwether - Law360
Humana Subsidiary iCare Selected for Family Care and Family Care Partnership Contracts Across Southeast Wisconsin - Business Wire
Glenmede Trust Co. NA Sells 3,698 Shares of Humana Inc. $HUM - MarketBeat
A Look at Humana Inc (HUM) After 3.3% Decline -- GF Value $366.9 - GuruFocus
Humana Inc Stock (HUM) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):